871709-92-1 Usage
Uses
Used in Medicinal Chemistry:
3-Amino-1H-indazole-6-carboxylic acid is used as a chemical intermediate for the synthesis of pharmaceutical compounds due to its ability to interact with biological systems and potentially modulate biological processes.
Used in Drug Discovery:
3-Amino-1H-indazole-6-carboxylic acid is used as a lead compound in drug discovery for its potential to be optimized and modified to develop new therapeutic agents with specific pharmacological activities.
Used in Chemical Modification and Optimization:
3-Amino-1H-indazole-6-carboxylic acid is used as a target for chemical modification and optimization in the development of new therapeutic agents, leveraging its structural features to enhance its pharmacological properties.
Further research and studies are necessary to fully explore the potential applications and therapeutic benefits of 3-Amino-1H-indazole-6-carboxylic acid in various fields of medicine and pharmaceuticals.
Check Digit Verification of cas no
The CAS Registry Mumber 871709-92-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,1,7,0 and 9 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 871709-92:
(8*8)+(7*7)+(6*1)+(5*7)+(4*0)+(3*9)+(2*9)+(1*2)=201
201 % 10 = 1
So 871709-92-1 is a valid CAS Registry Number.
871709-92-1Relevant articles and documents
N1/N2-Lactam Acetyl-CoA carboxylase inhibitors
-
Page/Page column 33, (2012/05/07)
The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof; wherein G is R1, R2 and R3 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal
3-AMINOINDAZOLES
-
, (2008/06/13)
Novel 3-aminoindazoles of formula (I) are SGK-inhibitors and can be used for treating SGK-related diseases and illnesses such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and renal diseases, and generally any type of fibroses and inflammatory processes.
